Gaya Amarasinghe, PhD – biochemical and biophysical methods to identify and characterize components from hosts and pathogens in order to develop an atomic resolution framework.

Beau Ances, MD, PhD – characterization of HIV-associated neurocognitive disorders and Alzheimer’s Disease using functional magnetic resonance imaging.

John Atkinson, MD – complement activation and regulation in innate and adaptive immunity.

Megan Baldridge, MD, PhD – commensal bacterial and viral interactions with the innate and adaptive immune system.

Rebecca Bart, PhD – genetics, molecular and computational biology to study how the environment affects the interactions between plants and microbes.

Stephen Beverley, PhD – molecular genetics and viruses of protozoan parasites including Leishmania.

Jacco Boon, PhD – molecular virology, pathogenesis and antiviral countermeasures against emerging RNA viruses.

Arpita Bose, PhD – microbial metabolisms and their influence on biogeochemical cycling using an interdisciplinary approach.

Juliane Bubeck Wardenburg, MD, PhD – fundamental principles of the interaction between bacterial pathogens including Staphylococcus aureus and the host.

Yin Cao, ScD, MPH – microbial and genetic risk factors for lung and gastrointestinal cancers leveraging large-scale clinical and population-based cohorts.

Michael Caparon, PhD – interactions of pathogenic Gram-positive bacteria including Streptococcus pyogenes with their human hosts.

Douglas Chalker, PhD – genetic and epigenetic regulation of developmentally programmed DNA rearrangements of Tetrahymena thermophila.

Matthew Ciorba, MD – microbial interactions relevant to intestinal inflammation and cancer including probiotics and mechanisms of intestinal SARS-CoV-2 infection.

Marco Colonna, MD – innate immune responses in infections, autoimmunity and tumors.

David Curiel, MD, PhD – gene therapy via engineering adenovirus tropism to achieve effective gene delivery.

Gautam Dantas, PhD – dynamics, ecology, and evolution of antibiotic resistance, engineering enhanced probiotics to treat gastrointestinal disorders, and engineering microbial biofuel catalysts.

Michael Diamond, MD, PhD – interface between viral pathogenesis and the host immune response in human pathogens such as Flaviviruses, Alphaviruses, and Coronaviruses, including SARS-CoV-2.

Mary Dinauer, MD, PhD – role of leukocyte NADPH oxidase in immune response to Aspergillus fumigatus, inflammation, and autoimmunity.

Siyuan Ding, PhD – interactions of rotavirus (RV), an important enteric viral pathogen, and SARS-CoV-2 with the host innate immune system in the small intestine.

Tamara Doering, MD, PhD – biology and pathogenesis of the pathogenic fungus Cryptococcus neoformans.

Brian Edelson, MD, PhD – how autoreactive T cells mediate autoimmune disease and activity of innate immune cells against bacterial and helminthic pathogens.

Ali Ellebedy, PhD – cellular and molecular mechanisms regulating memory B cell heterogeneity and fate in the context of influenza and SARS-CoV-2 vaccination.

Mario Feldman, PhD – pathogenesis of multidrug resistant bacteria and biogenesis of bacterial vesicles in the human gut.

Thomas A. Ferguson, PhD – role of the autophagy pathway in the function of the retina and in diseases of the eye.

Peter Fischer, DSc – medical helminthology, especially filariasis and other neglected tropical diseases caused by parasitic worms.

James Fleckenstein, MD – molecular investigation of enterotoxigenic Escherichia coli (ETEC).

Daved Fremont, PhD – mechanisms of host immunity and viral evasion.

Anthony French, MD, PhD – in vivo NK cell responses during viral infections.

Stephanie Fritz, MD, MSCI – asking and answering critical questions to guide clinical practice and ameliorate childhood suffering due to staphylococcal disease.

Eric Galburt, PhD – biophysical studies of transcription initiation in Eukaryotes and Mycobacterium tuberculosis.

Daniel Goldberg, MD, PhD – biochemistry of malaria.

Jeffrey Gordon, MD – role of the human gut microbiome in health and disease, notably childhood undernutrition and obesity.

Jeffrey Haspel, MD, PhD – impact of time as a biological variable in the development of critical illness such as sepsis, respiratory failure and chronic inflammatory lung disease.

Jeffrey Henderson, MD, PhD – biochemical interactions between humans and bacteria in health and disease.

Michael Holtzman, MD – pathogenesis and new therapeutics for viral infection and post-viral disease.

Henry Huang, PhD – molecular biology of Sindbis virus; antiviral drug design; monocyte differentiation.

Scott Hultgren, PhD – interdisciplinary approach to determine key aspects of bacterial pathogenesis and apply our knowledge to development of new therapeutics.

David Hunstad, MD – sex differences, virulence mechanisms, and novel therapeutics in E. coli urinary tract infection.

James Janetka, PhD – rational structure-based drug design and synthesis for cancer and infectious disease.

Andrew Janowski, MD – characterization of human diseases associated with novel viral infections.

Andrew Kau, MD, PhD – understanding the immune-modifying capacity of gastrointestinal and airway microbes through the lens of allergy.

Eynav Klechevsky, PhD – biology of different human dendritic cells and other myeloid cells as a key for manipulating immune responses in various disease conditions.

Robert Kranz, PhD – gene regulation and biogenesis of extracellular components in bacteria.

F. Matthew Kuhlmann, MD, MSCI – pre-clinical development of rationally designed Enterotoxigenic E. coli (ETEC) vaccines.

Hrishikesh Kulkarni, MD, MSCI – modulating host-pathogen interactions—especially the complement system—to mitigate pneumonia and acute lung injury.

Barbara Kunkel, PhD – molecular genetic analysis of disease development in Pseudomonas syringae-Arabidopsis interactions.

Sebla Kutluay, PhD – molecular biology of HIV-1-host interactions.

Jennie Kwon, DO, MSCI – microbial ecology of multidrug-resistant organisms (MDRO), and their relationship to the fecal microbiome and the microbiome of the built environment.

George Kyei, MB, ChB, PhD – HIV latency and reservoir maintenance.

Brian Laidlaw, PhD – investigating the development of immunological memory in disease states.

Janet Lee, MD – host immune response to extracellular Gram-negative respiratory pathogens, pulmonary host defense and lung injury.

Deborah Lenschow, MD, PhD – antiviral mechanisms of type I interferons and the role of interferons and viruses in autoimmune diseases.

Michele LeRoux, PhD – the molecular arms race between bacteria and phage.

Daisy Leung, PhD – defining molecular mechanisms at the host-pathogen interface.

Petra Levin, PhD – bacterial growth and antibiotic susceptibility.

Fangqiong Ling, PhD – bacterial colonization and transmission at the boundary of built and natural environments; microbiomes as environmental sensors and public health sentinels.

Ta-Chiang Liu, MD, PhD – understanding how host genetics and environmental factors interact to shape gut metabolism leading to inflammation.

Carolina López, PhD – how viruses interact with the body and how defective viruses influence the development of diseases in humans.

Elizabeth Mallott, PhD – how the environment shapes host-associated microbial communities both within and across species.

Todd Margolis, MD, PhD – cellular and molecular mechanisms that regulate the establishment and maintenance of latent neuronal infection with herpes simplex virus (HSV).

William McCoy, MD, PhD – how host-microbe interactions at epithelial barrier sites impact skin diseases.

Mark Miller, PhD – lymphoid tissue dynamics and antigen-presentation during infection, cancer and autoimmunity.

Makedonka Mitreva, PhD – next-generation experimental, multi-omic and computational approaches to empower the study of infectious diseases and the human microbiome.

Tae Seok Moon, PhD – building the future with synthetic biology.

S. Celeste Morley, MD, PhD – cell biology of the immune system — understanding how cytoskeletal control of cell motility and adhesion impacts host immunity to infection.

Anthony Orvedahl, MD, PhD – understanding factors that regulate host immune responses to infectious and sterile triggers of severe inflammation.

Slavica Pavlovic-Djuranovic, PhD – identifying new targets and possible therapies to treat malaria.

Jacqueline Payton, MD, PhD – regulation of the host immune response in bacterial and viral infections and the impact on blood cancers.

Jennifer Philips, MD, PhD – immune evasion by Mycobacterium tuberculosis.

Gwendalyn Randolph, PhD – inter-organ communication and the transit of cells and molecules out of tissues in healthy and disease states.

Lee Ratner, MD, PhD – molecular biology and pathogenesis of HIV and HTLV.

Courtney Reichhardt, PhD – investigating the fundamental biophysical principles of biofilm assembly.

Felipe Ribeiro, PhD – understanding the neuroimmune basis of infectious and non-infectious diseases.

David Rosen, MD, PhD – Pathogenesis and host response to Klebsiella pneumoniae infections.

Jai Rudra, PhD – development of nano-scale biomaterials for engaging the immune system to induce protective antibody and cell-mediated immune responses against diseases.

Drew Schwartz, MD, PhD – pediatric gut microbiome and immune disruption in serious bacterial infections.

Liang Shan, PhD – HIV infection and host immune response in humanized mouse models.

Chen Shen, PhD – Structural mechanisms of inflammasome signaling in detecting microbial pathogens.

David Sibley, PhD – cellular and molecular basis of intracellular parasitism by protozoan parasites.

Christina Stallings, PhD – molecular pathogenesis of Mycobacterium tuberculosis.

Ashley Steed, MD, PhD – genetic and environmental factors that underlie the mechanistic basis for the heterogeneity in outcomes in response to infection.

Joan Strassmann, PhD – social interactions and mutualism, using a microbial system to study cheating, conflict and cooperation, in particular in social amoebae and their farmed bacteria.

Eva-Maria Strauch, PhD – diagnose, prevent and treat viral infections with the aim of generating new antivirals and candidates for vaccination through protein design.

Siobhan Sutcliffe, PhD, ScM, MHS – infectious causes of cancer and chronic diseases.

Yinjie Tang, PhD – metabolism analysis and metabolic engineering of environmental microorganisms for biofuel/chemical production.

Phillip Tarr, MD – pathogenic interactions between microbes and the gut.

Heather True-Krob, PhD – epigenetic regulation of phenotypes by propagation of prions in yeast.

Aayushi Uberoi, PhD – understanding the interplay between microbiome, host, and environment in regulating skin barrier homeostasis and pathogenesis.

Michael Vahey, PhD – biophysical mechanisms of infectious disease.

Steven Van Dyken, PhD – cytokine-mediated tissue feedback loops that maintain homeostasis, and environmental factors that instigate inflammation and fibrosis.

Deborah Veis (Novack), MD, PhD – host:pathogen interactions in the bone microenvironment.

David Wang, PhD – discovery and characterization of novel viruses.

Gary J. Weil, MD – research is focused on filarial nematode parasites (translational research and biology).

Timothy Wencewicz, PhD – antibiotic drug discovery.

Sean Whelan, PhD – biology of negative-strand (NS) RNA viruses, divided between two major areas of focus: viral gene expression and viral-host cell interactions.

Meng Wu, PhD – tripartite interactions among the microbiota, stromal cells and the immune system.

Kristine Wylie, PhD – host-microbe dynamics during pregnancy.

Wayne Yokoyama, MD – host innate immune responses to tumors and pathogens.

Fuzhong Zhang, PhD – synthetic biology for advanced biofuels, biomaterials, and chemicals.